AIRLINK 80.55 Increased By ▲ 1.14 (1.44%)
BOP 5.28 Decreased By ▼ -0.05 (-0.94%)
CNERGY 4.39 Increased By ▲ 0.01 (0.23%)
DFML 34.79 Increased By ▲ 1.60 (4.82%)
DGKC 76.90 Increased By ▲ 0.03 (0.04%)
FCCL 20.65 Increased By ▲ 0.12 (0.58%)
FFBL 33.50 Increased By ▲ 2.10 (6.69%)
FFL 9.75 Decreased By ▼ -0.10 (-1.02%)
GGL 10.20 Decreased By ▼ -0.05 (-0.49%)
HBL 118.45 Increased By ▲ 0.52 (0.44%)
HUBC 135.60 Increased By ▲ 1.50 (1.12%)
HUMNL 7.04 Increased By ▲ 0.04 (0.57%)
KEL 4.67 No Change ▼ 0.00 (0%)
KOSM 4.70 Decreased By ▼ -0.04 (-0.84%)
MLCF 37.60 Increased By ▲ 0.16 (0.43%)
OGDC 137.00 Increased By ▲ 0.30 (0.22%)
PAEL 23.04 Decreased By ▼ -0.11 (-0.48%)
PIAA 27.17 Increased By ▲ 0.62 (2.34%)
PIBTL 6.91 Decreased By ▼ -0.09 (-1.29%)
PPL 113.40 Decreased By ▼ -0.35 (-0.31%)
PRL 27.49 Decreased By ▼ -0.03 (-0.11%)
PTC 14.75 No Change ▼ 0.00 (0%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.67 Decreased By ▼ -0.83 (-1.23%)
SSGC 11.05 Decreased By ▼ -0.04 (-0.36%)
TELE 9.27 Increased By ▲ 0.04 (0.43%)
TPLP 11.58 Increased By ▲ 0.02 (0.17%)
TRG 71.92 Decreased By ▼ -0.18 (-0.25%)
UNITY 25.60 Increased By ▲ 0.78 (3.14%)
WTL 1.36 Decreased By ▼ -0.04 (-2.86%)
BR100 7,590 Increased By 64.4 (0.86%)
BR30 24,769 Increased By 119.8 (0.49%)
KSE100 72,446 Increased By 474.4 (0.66%)
KSE30 23,926 Increased By 177.4 (0.75%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published May 7, 2020
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed.